# Gynius Plus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gynius-plus

- Industry: Medical Devices & Equipment
- Headquarters: Gothenburg, Sweden
- Website: https://gynius.se/
- Latest round: Seed (Apr 8, 2025)
- Investors on record: 1

## About

Gynius Plus AB, located in Sweden, specializes in innovative medical technologies, particularly advanced colposcopic solutions essential for gynecological practices.Gynius Plus AB is focused on providing advanced medical equipment for gynecological use. The company is headquartered in Gothenburg, Sweden. It was founded by a team of professionals with a background in healthcare technology. The company has one recorded deal, with the most recent funding occurring on April 8, 2025, when it raised venture funding from new investor SOSV.Gynius Plus AB specializes in the development and distribution of advanced colposcopic solutions, prominently featuring their flagship product, the Gynocular. This portable colposcope integrates state-of-the-art optics and LED technology, designed for ease of use and functionality. It serves as a vital tool in gynecological practices, facilitating HPV DNA screening, colposcopy-assisted Visual Inspection with Acetic Acid (VIA), and treatment procedures. The Gynocular is particularly noted for its lightweight design, allowing healthcare professionals to carry it conveniently in a pocket or small bag. Gynius Plus AB targets a diverse clientele, including gynecologists, clinics, and healthcare facilities in various international markets, enhancing cervical cancer detection and management capabilities worldwide.Gynius Plus AB operates on a revenue model that encompasses direct sales and potential partnerships with healthcare institutions. Clients acquire the Gynocular through direct purchases, and there may be offerings related to ongoing services and support for the product, ensuring optimal performance in clinical settings. Additionally, the company could explore subscription-based models for recurring services or upgrades associated with their products. The revenue generation strategy emphasizes the provision of high-quality medical devices tailored for gynecological use, supporting the detection and treatment of cervical cancer. The company's focus on innovation and quality positions it favorably in the healthcare sector, contributing to its overall business development and client satisfaction.Gynius Plus AB is actively designing new products to expand its offerings in the medical technology space. The company is targeting specific international markets for expansion, with plans to enter these regions by the end of 2025. The recent funding raised in April 2025 will be utilized to support these initiatives, ensuring the development of new products and facilitating market entry.

## Funding rounds

- Seed, Apr 8, 2025 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed